Search

everythinglearnresearchcommunity

for

Search:↓

Flutamide effectively treats female pattern hair loss with low doses showing good liver tolerance.

Antiandrogenic pretreatment for women with PCOS does not improve fertility outcomes and delays pregnancy.

The study concluded that different treatments reduced post-COVID symptoms over time and that factors like age, severity, and comorbidities affect symptom risk.

CDK4/6 inhibitors may cause hair loss in breast cancer patients.

COVID-19 infection rates were low in patients with immune diseases, regardless of their treatment type.

The study aims to understand how mood, physical activity, light exposure, and seasonal changes affect sleep patterns.

The study aims to understand the skin and hair characteristics of mothers and their babies, and how these may affect newborns' skin health and mothers' postpartum hair loss.

Women with PCOS have a higher risk of diabetes and heart problems, especially when they get older.

High doses of cyproterone acetate are linked to an increased risk of developing meningioma.

Some breast cancer patients still experience hair loss three years after chemotherapy, especially with taxane-based treatments.

Anti-androgens, like finasteride, dutasteride, and spironolactone, may lessen the severity of COVID-19 in men, leading to fewer ICU admissions.

Chemotherapy causes hair loss starting soon after treatment begins and recovers about 3 months after ending, while tamoxifen does not significantly affect hair growth.

Black patients with discoid lupus erythematosus have more severe skin damage and higher chances of dyspigmentation, scalp, and ear involvement.

Adult acne severity is influenced by stress, skin sensitivity, makeup, stopping oral contraceptives, and requires female-specific treatment guidelines.

Asian patients with Frontal Fibrosing Alopecia often lose eyebrow hair and respond well to combined antiandrogen or antimalarial and topical treatments.

Men with frontal male pattern baldness may have a higher risk of gastric cancer.

Finasteride use may increase the risk of male breast cancer.

Early treatment of fibrosing alopecia in a pattern distribution may improve outcomes.

People who get alopecia areata after age 50 usually have mild symptoms, high chances of hair regrowth, and often have other health conditions.

Upadacitinib improved hair regrowth and quality of life in alopecia areata patients with minimal side effects.

A model using hormone levels, cycle length, and BMI can help identify PCOS in Chinese women but isn't for screening teens.

Taking high doses of Cyproterone acetate significantly increases the risk of meningioma in females.

Adding antihistamines to topical corticosteroid and cryotherapy may improve hair regrowth in alopecia areata patients.

Hair loss doesn't affect COVID-19 severity.

People with alopecia areata are more likely to get migraines, and vice versa.

Degenerative changes in the lower cervical spine are common in patients with abnormal scalp sensations, with some improvement seen using pain medication and physical therapy.

Laser treatment and deroofing are effective options for hidradenitis suppurativa.

Hormonal intrauterine devices (IUDs) may cause or worsen skin conditions influenced by androgens.

Both terazosin and baclofen effectively reduce pain in young men with chronic testicular pain, with no difference in their effectiveness.

Metabolic syndrome reduces effectiveness of hair loss treatment.